Your price won'tPlexusDx charges a flat monthly rate regardless of whether you're at 0.25 mg or 2.4 mg, removing financial barriers to reaching your optimal therapeutic level
Foundayo is approved for: Adults with a BMI of 30 or higher (obesity classification) Adults with a BMI of 27 or higher who also have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or abnormal cholesterol Foundayo is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, consistent with other GLP-1 receptor agonists
It encourages higher levels of energy expenditure and physical activity while suppression age-related weight gain
Disclaimer: The Medicare GLP-1 Bridge is a federal program administered by CMS
The World Health Organization last month put out a warning against these fake products, which could lead to toxic reactions in patients
Your decision may depend on availability as both medications are known to be in shortage